SAMSUNG TO INVEST $389 MILLION IN BIOSIMILARS: REPORT (REUTERS)

Reuters - South Korea's Samsung Electronics plans to invest about 500 billion won ($389 million) in the biotech medicine business, a local internet news provider said on Wednesday, quoting a top policymaker.